The American Journal of Surgery
Volume 200, Issue 4 , Pages 454-461 , October 2010

Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis

Presented in part at the 2007 Clinical Congress of the American College of Surgeons, October 7, 2007, New Orleans, LA.

Received 14 August 2009 ,Revised 30 October 2009

References 

  1. Davies L, Welch H. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295:2164–2167
  2. Hodgson NC, Button J, Solorzano CC. Thyroid cancer: is the incidence still increasing?. Ann Surg Oncol. 2004;11:1093–1097
  3. Haselkorn T, Bernstein L, Preston-Martin S, et al. Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972–95. Cancer Causes Control. 2000;11:163–170
  4. Burgess JR, Tucker P. Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology. Thyroidology. 2006;16:47–53
  5. Clegg LX, Reichman ME, Miller BA, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the Surveillance, Epidemiology and End Results: National Longitudinal Mortality Study. Cancer Causes Control. 2009;20:417–435
  6. Percy C, Fritz A, Jack A. International Classification of Diseases for Oncology. 3rd ed.. Geneva: World Health Organization; 2000;
  7. Hedinger C, Williams ED, Sobin LH. Histological typing of thyroid tumors. 2nd ed.. Berlin: Springer; 1988;
  8. Morris LG, Sikora AG, Myssiorek D, et al. The basis of racial differences in the incidence of thyroid cancer. Ann Surg Oncol. 2008;15:1169–1176
  9. Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for Joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–351
  10. Verkooijen HM, Fioretta G, Pache JC, et al. Diagnostic changes as a reason for an increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control. 2003;14:13–17
  11. Leenhardt L, Bernier MO, Boin-Pineau MH, et al. Advances in diagnostic practices affect thyroid cancer incidence in France. Eur J Endocrinol. 2004;150:133–139
  12. VanderLaan W. The occurrence of carcinoma of the thyroid gland in autopsy material. N Engl J Med. 1947;237:221–222
  13. Bondeson L, Ljungberg O. Occult thyroid cancer at autopsy in Malmo, Sweden. Cancer. 1981;47:319–323
  14. Heitz P, Moser H, Staub JJ. Thyroid cancer: a study of 573 thyroid tumors and 161 autopsy cases observed over a thirty year period. Cancer. 1976;37:2329–2337
  15. Solares CA, Penalonzo MA, Xu M, et al. Occult papillary thyroid carcinoma in postmortem species: prevalence at autopsy. Am J Otolaryngol. 2005;26:87–90
  16. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid: a “normal” finding in Finland. Cancer. 1985;56:531–538
  17. Belfiore A, LaRosa GL, LaPorta GA, et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine uptake, sex, age and multinodularity. Am J Med. 1992;93:363–369
  18. Hall EJ, Brenner DJ. Cancer risks from diagnostic radiology. Br J Radiol. 2008;81:362–378
  19. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer. 2009;115:3801–3807
  20. Heller KS. Do all cancers need to be treated? (The role of thyroglobulin in the management of thyroid cancer). Arch Otolaryngol Head Neck Surg. 2007;133:639–643
  21. Hughes CJ, Shaha AR, Shah JP, et al. Impact of lymph node metastases in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck. 1996;18:127–132
  22. Iribarren C, Haselkorn T, Tekawa IS, et al. Cohort study of thyroid cancer in a San Francisco Bay Aarea population. Int J Cancer. 2001;93:745–750
  23. Grodski S, Brown T, Sidhu S, et al. Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery. 2008;144:1038–1043

PII: S0002-9610(10)00081-4

doi: 10.1016/j.amjsurg.2009.11.008

The American Journal of Surgery
Volume 200, Issue 4 , Pages 454-461 , October 2010